SCHEMBL1162373

SCHEMBL1162373

CC(c1ccccc1S(=O)(=O)Cl)[Si](Cl)(Cl)Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TRPV4 Q9HBA0 2/20 0.36
MMP1 P03956 2/20 0.33
MMP2 P08253 2/20 0.33
MMP9 P14780 2/20 0.33
MMP8 P22894 2/20 0.33
MMP12 P39900 2/20 0.33
MMP13 P45452 2/20 0.33
MMP14 P50281 2/20 0.33
MMP16 P51512 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD11B1 P28845 1/20 0.31
POLB P06746 1/20 0.31
HTR2A P28223 2/20 0.31
HTR2C P28335 2/20 0.31
KCNH2 Q12809 2/20 0.31
MMP3 P08254 1/20 0.31
CA1 P00915 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1162678 0.84 ALDH1A1 (0.35) ALDH1A1HSD17B10TDP1TRPV4
SCHEMBL1162496 0.81 TRPV4 (0.36) ALDH1A1HSD17B10TDP1TRPV4MMP1
SCHEMBL1415493 0.80 L3MBTL1 (0.46) ALDH1A1HSD17B10TDP1TRPV4MMP1
SCHEMBL10645229 0.79 ALDH1A1 (0.38) ALDH1A1HSD17B10TDP1TRPV4MMP1
SCHEMBL8713730 0.77 GABRA1 (0.39) ALDH1A1HSD17B10L3MBTL1HTR2CCA1
SCHEMBL4455751 0.77 TRPV4 (0.35) ALDH1A1HSD17B10TDP1TRPV4
SCHEMBL10627469 0.77 P2RX7 (0.37) ALDH1A1HSD17B10TDP1TRPV4MMP1
SCHEMBL1415486 0.74 TRPV4 (0.40) ALDH1A1HSD17B10TDP1TRPV4MMP1
SCHEMBL1501176 0.74 ALDH1A1 (0.34) ALDH1A1HSD17B10TDP1TRPV4MMP1
SCHEMBL10641545 0.74 ALDH1A1 (0.41) ALDH1A1HSD17B10TDP1TRPV4MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2343544-B1 Method for analyzing hemoglobin by electrophoresis ARKRAY INC (JP) 2015-03-11 EP disclosed
EP-1548020-B1 SILICON COMPOUND JNC CORP (JP) 2014-07-23 EP disclosed
US-8702941-B2 Method of analyzing hemoglobin by electrophoresis ARKARY, Inc. (JP) 2014-04-22 US disclosed
WO-2013173501-A2 CHROMATOGRAPHIC MATERIALS WATERS TECHNOLOGIES CORPORATION (US) 2013-11-21 WO disclosed
WO-2013158277-A1 METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY WATERS TECHNOLOGIES CORPORATION (US) 2013-10-24 WO disclosed
EP-2462188-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER Waters Technologies Corporation (US) 2012-06-13 EP disclosed
EP-2343544-A1 Method for analyzing hemoglobin by electrophoresis Arkray, Inc. (JP) 2011-07-13 EP disclosed
US-20110155573-A1 METHOD OF ANALYZING HEMOGLOBIN BY ELECTROPHORESIS ARKRAY, INC. (JP) 2011-06-30 US disclosed
WO-2011017418-A1 HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER WATERS TECHNOLOGIES CORPORATION (US) 2011-02-10 WO disclosed
US-7294732-B2 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers CHISSO CORPORATION (JP) 2007-11-13 US disclosed
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers JNC CORPORATION (JP) 2005-12-29 US disclosed
EP-1548020-A1 SILICON COMPOUND CHISSO CORPORATION (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers STS, SULT1A1, SRM ALDH1A1 384/4885HSD17B10 1153/4885TDP1 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.